IN2014DN07895A - - Google Patents

Info

Publication number
IN2014DN07895A
IN2014DN07895A IN7895DEN2014A IN2014DN07895A IN 2014DN07895 A IN2014DN07895 A IN 2014DN07895A IN 7895DEN2014 A IN7895DEN2014 A IN 7895DEN2014A IN 2014DN07895 A IN2014DN07895 A IN 2014DN07895A
Authority
IN
India
Prior art keywords
drug
exchange resin
cation exchange
present
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Vinod Kumar Arora
Jatin Khurana
Deepak Gaikwad
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN7895DEN2014 priority Critical patent/IN2014DN07895A/en
Publication of IN2014DN07895A publication Critical patent/IN2014DN07895A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN7895DEN2014 2012-02-21 2013-02-21 IN2014DN07895A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN7895DEN2014 IN2014DN07895A (enExample) 2012-02-21 2013-02-21

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN496DE2012 2012-02-21
IN7895DEN2014 IN2014DN07895A (enExample) 2012-02-21 2013-02-21
PCT/IB2013/051432 WO2013124818A1 (en) 2012-02-21 2013-02-21 Taste masked dispersible tablets

Publications (1)

Publication Number Publication Date
IN2014DN07895A true IN2014DN07895A (enExample) 2015-04-24

Family

ID=54261187

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7895DEN2014 IN2014DN07895A (enExample) 2012-02-21 2013-02-21

Country Status (10)

Country Link
US (1) US20150031647A1 (enExample)
EP (1) EP2816997A1 (enExample)
CN (1) CN104203212A (enExample)
AP (1) AP2014007934A0 (enExample)
AU (1) AU2013223705A1 (enExample)
CA (1) CA2865312A1 (enExample)
IN (1) IN2014DN07895A (enExample)
MX (1) MX2014010038A (enExample)
SG (1) SG11201405053SA (enExample)
WO (1) WO2013124818A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6577024B2 (ja) * 2014-05-08 2019-09-18 シーティーシー バイオ インコーポレイテッド 味が遮蔽されたクロミプラミン含有経口投与用薬学製剤
CN112353802A (zh) * 2020-11-26 2021-02-12 山东诚创蓝海医药科技有限公司 一种富马酸伏诺拉生掩味组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032245A1 (en) 2000-07-27 2002-03-14 Lyn Hughes Resinate composition
US20040067216A1 (en) 2002-02-22 2004-04-08 Karki Shyam B. Hiv protease inhibitors supported on cation exchange resins for oral administration
EP2198857A1 (en) * 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
EP2519264A1 (en) * 2009-12-31 2012-11-07 Ranbaxy Laboratories Limited Taste masked dosage forms of bitter tasting anti-retroviral drugs

Also Published As

Publication number Publication date
WO2013124818A1 (en) 2013-08-29
CA2865312A1 (en) 2013-08-29
AP2014007934A0 (en) 2014-09-30
SG11201405053SA (en) 2014-09-26
CN104203212A (zh) 2014-12-10
AU2013223705A1 (en) 2014-09-11
EP2816997A1 (en) 2014-12-31
US20150031647A1 (en) 2015-01-29
MX2014010038A (es) 2014-12-05

Similar Documents

Publication Publication Date Title
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
IN2015DN03984A (enExample)
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
PH12016501122B1 (en) Delayed release compositions of linaclotide
IN2013MU03583A (enExample)
PH12016501841A1 (en) Immunosuppressant formulation
SG11201405294XA (en) Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative
HK1217650A1 (zh) 用於治疗剧痛的组合物及方法
IN2014MN02236A (enExample)
IN2014DN06966A (enExample)
IL243786A0 (en) A drug that contains a pharmaceutical combination of dolutegravir, emtricitabine and tenofovir
PH12016500847A1 (en) Multi-particulate drug delivery system
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
AP2015008208A0 (en) Pharmaceutical administration forms comprising
HUP1300647A2 (hu) Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
MX2016007682A (es) Composicion farmaceutica que comprende ivabradina amorfa.
IN2013MU01985A (enExample)
IN2013MU01111A (enExample)
MX2016002560A (es) Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
MX2014010038A (es) Tabletas dispersables con sabor enmascarado.
MX2015009077A (es) Composicion estable que contiene fingolimod.
IN2013CH04314A (enExample)
SG10201700267PA (en) Prophylactic or therapeutic drug for constipation